SCHEMBL27315205

SCHEMBL27315205

CC(C)c1cc(C(=O)Nc2ccc3c(c2)COC3)c2c(N)ncnn12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NTRK1 P04629 3/20 0.54
▸ NTRK2 Q16620 4/20 0.52
▸ KDR P35968 3/20 0.41
▸ RET P07949 2/20 0.41
▸ MERTK Q12866 5/20 0.41
▸ AURKB Q96GD4 2/20 0.40
▸ AURKA O14965 1/20 0.40
▸ TYRO3 Q06418 3/20 0.40
▸ AXL P30530 4/20 0.39
▸ CSNK2A2 P19784 3/20 0.39
▸ CSNK2A1 P68400 3/20 0.39
▸ IKBKB O14920 1/20 0.38
▸ PDPK1 O15530 1/20 0.38
▸ EGFR P00533 1/20 0.38
▸ LCK P06239 1/20 0.38
▸ FYN P06241 1/20 0.38
▸ CDK1 P06493 1/20 0.38
▸ LYN P07948 1/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ MARK3 P27448 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27315264 0.81 AXL (0.48) MERTKAURKBAURKATYRO3AXL
SCHEMBL27315170 0.80 NTRK1 (0.57) NTRK1NTRK2KDRRETMERTK
SCHEMBL27315227 0.78 NTRK1 (0.55) NTRK1NTRK2KDRRETMERTK
SCHEMBL27315615 0.78 NTRK1 (0.58) NTRK1NTRK2RET
SCHEMBL27315176 0.78 NTRK1 (0.55) NTRK1NTRK2KDRRETMERTK
SCHEMBL27315622 0.76 NTRK1 (0.39) NTRK1NTRK2RET
SCHEMBL1925743 0.75 NTRK1 (0.79) NTRK1NTRK2KDRAURKBAURKA
SCHEMBL27315108 0.74 NTRK1 (0.57) NTRK1NTRK2KDRRETCSNK2A2
SCHEMBL27315059 0.72 NTRK1 (0.56) NTRK1NTRK2KDRRETAURKA
SCHEMBL1924757 0.70 NTRK1 (1.00) NTRK1NTRK2KDRRETAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4611900-A1 RET-LDD PROTEIN INHIBITORS Bristol-Myers Squibb Company (US) 2025-09-10 — — EP disclosed
WO-2024097980-A1 RET-LDD PROTEIN INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2024-05-10 — — WO disclosed
Send feedback